Dr Sue Pavord

A pioneer in Obstetric Haematology, she has been instrumental in establishing this field as a recognised subspecialty over the past 25 years. Through her research, education, and authorship of national and international guidelines, as well as a leading textbook, she has shaped practice and advanced standards of care worldwide.

She played a pivotal role in defining vaccine-induced immune thrombocytopenia and thrombosis (VITT) as a new syndrome associated with COVID-19 vaccination. As Chair of the UK Expert Haematology Panel on VITT, she guided national management strategies that significantly reduced morbidity and mortality and prevented further cases. She is also a recognised authority in immune thrombocytopenia (ITP), having led the development of national consensus guidance for the management of adults with new and relapsed ITP during the COVID-19 pandemic. She is a former Director of the Leicester Comprehensive Care Haemophilia and Thrombosis Centre and current Director of the Oxford University Hospitals’ Haematology Laboratories.

Dr Pavord has authored more than 200 peer-reviewed publications, contributing to the advancement of haematology practice.

She is Fellow of both the Royal College of Physicians and Royal College of Pathologists and President of the British Society for Haematology.